1Monroe DM, Key NS. The tissue factor-factor Ⅶa complex:procoagulant activity, regulation, and multitasking. J Thromb Haemost, 2007,5 ( 6 ) : 1097-1105.
2Dusse LM, Cooper A J, Lwaleed BA. Tissue factor and nitric oxide: a controversial relationship ! J Thromb Thrombolysis, 2007,23 ( 2 ) : 129- 133.
3Wiiger MT, Prydz H. The changing faces of tissue factor biology. A personal tribute to the understanding of the " extrinsic coagulation activation". Thromb Haemost ,2007,98 ( 1 ) :3842.
4Steffel J, Luscher TF, Tanner FC. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation, 2006, 113(5) :722-731
6Mackman N, Tilley RE, Key NS. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol, 2007,27 ( 8 ) : 1687-1689.
7Ott I ,Michaelis C,Schuermann M ,et al. Vascular remodeling in mice lacking the cytoplasmic domain of tissue factor. Circ Res ,2005,97 (3) :293- 298.
8Luscher TF, Steffel J, Eberli FR,et al. Drug-eluting stent and coronary thrombosis:biological mechanisms and clinical implications. Circulation, 2007,115 (8) :1051-1058.
9Weerasinghe A, Athanasiou T, Philippidis P, et al. Platelet-monocyte procoagulant interactions in on-pump coronary surgery. Eur J Cardiothorac Surg,2006,29 (3) :312-318.
10Paparella D, Galeone A, Venneri MT, et al. Activation of the coagulation system during coronary artery bypass grafting: comparison between onpump and off-pump techniques. J Thorac Cardiovasc Surg, 2006, 131 (2) :290-297.
8Magee M J, Alexander JH, Hafley G, et al. Coronary artery bypass graft failure after on-pump and off-pump coronary artery bypass:findings from PREVENT IV. Ann Thorac Surg,2008,85:494-500.
9Gaffney MM, Hynes SO, Barry F, et al. Cardiovascular gene therapy: current status and therapeutic potential. Br J Pharmacol, 2007,152: 175-188.
10Rosenfeldt F, He GW, Roubos N. Vein graft neointimal hyperplasia: prevention is better than cure. J Thorac Cardiovasc Surg,2007,133: 1118-1119.
